Management of Gastrointestinal Involvement in Scleroderma

Abstract

Gastrointestinal tract (GIT) is commonly involved in patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to signif-icant dysmotility causing complications like malabsorption, weight loss, and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient-reported outcome measures in SSc-GI involvement has also been incorporated.